ARPEGE project fits within the general framework of maintaining functional autonomy in the frail elderly. The early identification of elderly people at risk of frailty is essential to be able to make corrective actions to maintain a quality of life desired by the person. ARPEGE offers tracking and monitoring based on a corpus mobile evaluation of frailty, that could be used in various environments (home, prevention center, office of the general practitioner, geriatric consultation), and manipulated intuitively by professionals not specialists.
This four-year project spearheaded by the University of technology of Troyes in partnership with the University of Reims Champagne-Ardenne also brings a set of partners and experts in the region and outside, so that the proposed solution has the qualities necessary for its deployment in terms of value diagnostic, use, acceptability and perfectly controlled ethics.
The Region has made "longevity aging" theme one of its priorities. This image of driver of innovation in this area can only be enhanced by a program like ARPEGE. Beyond the scientific and technological results expected, one can imagine the potential socio-economic benefits if this tracking solution is deployed on a large scale.
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Other
- Masking: None (Open Label)
- Study Primary Completion Date: October 14, 2014
- Other: evaluation of frailty
Clinical Trial Outcome Measures
- Duke Health Profile: Quality of life questionnaire
- Time Frame: up to 36 months
- The Duke Health Profile is a generic health-related quality of life questionnaire that comprises 17 items grouped in 10 scales: physical health, mental health, social health, general health (aggregate score of the 3 previous scales), perceived health, self-esteem, anxiety, depression, pain, and disability. Scores of each scale range from 0 to 100, with 100 representing optimum quality of life.
Participating in This Clinical Trial
- 70 years or older
- GIR 4, 5 or 6
- Consenting to participate in the study
- Severe cognitive impairment ( MMSE < 10)
- Major neurosensory disorders
- Full hospitalization or not (acute care and rehabilitation..)
- Non- affiliation to a social security scheme
- Major protected by law (guardianship, trusteeship)
- Informed consent not provide
Gender Eligibility: All
Minimum Age: 70 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- CHU de Reims
- Provider of Information About this Clinical Study
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.